Dr. Ankit D. Kanthe is an Analytical Scientist in the Sterile Drug Product Development group at Bristol Myers Squibb. He has been involved in formulation development and analytical characterization of drug products, including monoclonal antibodies, fusion proteins, and oral solids. His expertise lies in the field of interfacial science to understand protein-excipient interactions.
Ankit completed his Ph.D. in chemical engineering from the City University of New York – City College, NY, and his undergraduate studies in chemical engineering from University Institute of Chemical Technology, Mumbai, India. The talk is a part of the Attension Seminar 2021.